Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.1K

Exploring monocarboxylate transporter inhibition for cancer treatment

Tomas Koltai1, Larry Fliegel2

  • 1Hospital del Centro Gallego de Buenos Aires, Buenos Aires 2199, Argentina.

Exploration of Targeted Anti-Tumor Therapy
|March 11, 2024
PubMed

Insights

Monocarboxylate transporters (MCTs) are crucial for cell transport and are emerging as targets for cancer therapy. New inhibitors show promise by blocking lactate transport, though further research is needed to optimize their anticancer effects.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cell membranes regulate solute transport via transporters like Monocarboxylate Transporters (MCTs).
  • MCTs are part of the Solute Carrier (SLC) family, highlighting their biological significance with 446 identified genes.
  • Recent research emphasizes MCTs' role in cancer development and their potential as therapeutic targets.

Purpose of the Study:

  • To review the structure, function, and role of MCTs in cancer.
  • To discuss existing and novel monocarboxylate inhibitors.
  • To explore strategies for enhancing the anticancer efficacy of MCT inhibitors.

Main Methods:

  • Literature review of MCT structure and function.
  • Analysis of MCTs' involvement in cancer progression.
  • Compilation and discussion of various monocarboxylate inhibitors and their mechanisms.

Main Results:

  • MCTs are essential for transporting small molecules across cell membranes.
  • MCTs play a significant role in cancer development and progression.
  • Current inhibitors primarily target lactate transport, with ongoing investigation into their precise mechanisms.

Conclusions:

  • MCTs are vital targets for cancer treatment.
  • Developing effective MCT inhibitors is a recent and active area of research.
  • Further studies are needed to refine inhibitors and improve their clinical outcomes.
Keywords:
AZD3965Monocarboxylate transportersdiclofenacglycolytic metabolismlactatelactate shuttlequercetin

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
422
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K